Epilepsy; USFDA to authorize clinical trials for use of cannabidiol oil, etc., for treatment. (HR242)

Introduced By

Del. Bob Marshall (R-Manassas)

Progress

Introduced
Passed Committee
Passed House
Passed Senate

Description

Memorializing the U.S. Food and Drug Administration to authorize clinical trials; cannabidiol oil and THC-A oil. Expresses the sense of the House of Delegates that the U.S. Food and Drug Administration be urged to authorize clinical trials to determine the efficacy of using cannabidiol oil and THC-A oil for the treatment of epilepsy. Read the Bill »

Outcome

Bill Has Failed

History

DateAction
02/11/2015Committee
02/11/2015Presented and ordered printed 15105015D
02/11/2015Referred to Committee on Rules
02/20/2015Tabled in Rules